Submitted on Friday 18th September 2015
Published on Tuesday 22nd September 2015
Current status: Closed
Closed: Tuesday 22nd March 2016
Signatures: 1,560
Reinstate bevacizumab (Avastin) for cervical cancer on the Cancer Drugs Fund
Jo’s Cervical Cancer Trust is calling for the drug bevacizumab (Avastin) for cervical cancer to be reinstated onto the Cancer Drugs Fund (CDF) list after the announcement that it will be de-listed for cervical cancer treatment from the 4th November 2015.
Without bevacizumab, hundreds of women annually with late stage cervical cancer will be denied a drug that has shown to increase the median survival by 3.7 months with a small impact on quality of life.
The removal of bevacizumab, which had just started to fulfill a large and unmet need, will result in a hugely detrimental impact on end of life for cervical cancer patients.
We’re calling on NHS England and Pharma to resolve this issue and come to an agreement on affordability.
You can't sign this petition because it is now closed. But you can still comment on it here at Repetition.me!
3.128.168.219 Sun, 22 Dec 2024 07:09:21 +0000
